Page last updated: 2024-11-05

4-trifluoromethylaniline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-trifluoromethylaniline : A substituted aniline that is a benzene ring substituted with an amino group at position 1 and a trifluoromethyl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9964
CHEMBL ID1162294
CHEBI ID40750
SCHEMBL ID10302
MeSH IDM0132156

Synonyms (83)

Synonym
EN300-20241
4-(trifluoromethyl)aniline
p-aminobenzotrifluoride
.alpha.,.alpha.-trifluoro-p-anisidine
455-14-1
4-aminobenzotrifluoride
nsc10337
benzenamine, 4-(trifluoromethyl)-
p-(trifluoromethyl)aniline
aniline, p-(trifluoromethyl)-
nsc-10337
.alpha.,.alpha.-trifluoro-p-toluidine
4-(trifluoromethyl)benzenamine
p-amino-.alpha.,.alpha.-trifluorotoluene
p-toluidine,.alpha.,.alpha.-trifluoro-
inchi=1/c7h6f3n/c8-7(9,10)5-1-3-6(11)4-2-5/h1-4h,11h
4-(trifluoromethyl)aniline, 99%
brn 1564853
p-trifluoromethylaniline
p-amino-alpha,alpha,alpha-trifluorotoluene
p-toluidine, alpha,alpha,alpha-trifluoro-
4-trifluoromethylaniline
alpha,alpha,alpha-trifluoro-p-toluidine
einecs 207-236-5
nsc 10337
AC-028
A0662
chebi:40750 ,
4-(trifluoromethyl)benzenaminium
CHEMBL1162294
AKOS000119383
[4-(trifluoromethyl)-phenyl]-amine
a,a,a-trifluoro-p-toluidine
4-trifluoromethyl-phenylamine
1-amino-4-(trifluoromethyl)benzene
STL164343
ec 207-236-5
para-trifluoromethylaniline
unii-rqj623mb8g
rqj623mb8g ,
4-12-00-01982 (beilstein handbook reference)
4-(trifluoromethyl)phenylamine
FT-0619541
leflunomide impurity a
AM20060250
SCHEMBL10302
4-tfma
leflunomide impurity a [ep impurity]
.alpha.,.alpha.,.alpha.-trifluoro-p-toluidine
teriflunomide metabolite (4-tfma)
(4-(trifluoromethyl)phenyl)amine
DTXSID5060013
4-trifluoromethyl phenylamine
4-trifluoromethyl aniline
[4- (trifluoromethyl)phenyl] amine
4-(trifluoro methyl) aniline
4-trifluoromethyl phenyl amine
4-amino-benzotrifluoride
4-(trifluoromethyl)-aniline
4-trifluoromethyl-aniline
4-trifluoro methyl aniline
4-trifluoromethylphenylamine
4-amino benzotrifluoride
4-trifluormethylaniline
4-(trifluoromethyl) aniline
[4-(trifluoromethyl)phenyl]amine
para-aminobenzotrifluoride
4-aminobenzotrifluororide
p-amino-.alpha.,.alpha.,.alpha.-trifluorotoluene
4-amino-.alpha.,.alpha.,.alpha.-benzotrifluoride
4-aminobenzotrifluoride hydrochloride (salt/mix)
p-toluidine, .alpha.,.alpha.,.alpha.-trifluoro-
Q-200434
PS-8765
mfcd00064396
F2190-0436
leflunomide impurity a, european pharmacopoeia (ep) reference standard
CS-W019629
Q27120406
gcgaknykkhxojp-uhfffaoysa-n
D77859
xsaleibqorddcl-uhfffaoysa-n
Z104477456
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
substituted aniline
(trifluoromethyl)benzenesAn organofluorine compound that is (trifluoromethyl)benzene and derivatives arising from substitution of one or more of the phenyl hydrogens.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID342464Dissociation constant, pKa of the compound2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
The many roles for fluorine in medicinal chemistry.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (16.13)18.7374
1990's20 (64.52)18.2507
2000's6 (19.35)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.93 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index54.24 (26.88)
Search Engine Supply Index2.06 (0.95)

This Compound (38.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]